This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
Epidemiology is the study and analysis of health and disease situations in specified populations, including their distribution (who, when, and where), patterns, and factors. It is a cornerstone of public health, influencing policy and evidence-based practise by identifying disease risk factors and preventative healthcare priorities. Epidemiologists assist in study design, data collection, statistical analysis, interpretation, and dissemination (including peer review and ccasional systematic review). Epidemiology has aided in the development of techniques for clinical research, public health investigations, and, to a lesser extent, basic biological science research. The measurement of disease outcomes in relation to a population at risk is a key component of epidemiology. The population at risk is a group of people, healthy or sick, who would be considered cases if they had the disease under investigation.
Epigenetics is the study of how your behaviour and environment can influence how your genes function. Epigenetic alterations, unlike genetic changes, are reversible and do not alter your DNA sequence; nevertheless, they can alter how your body interprets a DNA sequence. The study of how cells influence gene activity without modifying the DNA sequence is known as epigenetics. In Greek, "epi-" means "on or above," thus "epigenetic" refers to influences other than the genetic code. Modifications to DNA that control whether genes are turned on or off are known as epigenetic changes. These changes are made to DNA and do not alter the sequence of the DNA building units.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia